Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MESNA Injection for TMJ Internal Derangement
NCT05882604Completed
- Sponsor
- Tanta University
- Start
- Mar 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of mesna in temporomandibular joint internal derangement (TMJID) (2 arms), sponsored by Tanta University. Primary endpoint: Maximal Interincisal Opening at 6 months. Started Mar 2023; status: completed.
02
Drugs
mesna
03
Conditions
temporomandibular joint internal derangement (TMJID)
Beyond the preview
Go deeper on NCT05882604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05882604.